

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.78523873 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.75544743 |
| 3 | locomotory exploration behavior (GO:0035641) | 6.44428246 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.82605704 |
| 5 | * positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.78202097 |
| 6 | vocalization behavior (GO:0071625) | 5.69056848 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.51495620 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.48807824 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.40757841 |
| 10 | glutamate secretion (GO:0014047) | 5.37692793 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.22686338 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.17188461 |
| 13 | cerebellar granule cell differentiation (GO:0021707) | 5.13783155 |
| 14 | neuronal action potential propagation (GO:0019227) | 4.81494569 |
| 15 | exploration behavior (GO:0035640) | 4.78898118 |
| 16 | neurotransmitter secretion (GO:0007269) | 4.77777459 |
| 17 | protein localization to synapse (GO:0035418) | 4.76085510 |
| 18 | * regulation of neuronal synaptic plasticity (GO:0048168) | 4.72875781 |
| 19 | amino acid import (GO:0043090) | 4.72108443 |
| 20 | regulation of synapse structural plasticity (GO:0051823) | 4.70759280 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 4.69825818 |
| 22 | * ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.64712015 |
| 23 | * regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.55092711 |
| 24 | layer formation in cerebral cortex (GO:0021819) | 4.39403689 |
| 25 | gamma-aminobutyric acid transport (GO:0015812) | 4.38961492 |
| 26 | dendritic spine morphogenesis (GO:0060997) | 4.34153451 |
| 27 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.33009139 |
| 28 | potassium ion homeostasis (GO:0055075) | 4.31913752 |
| 29 | cellular potassium ion homeostasis (GO:0030007) | 4.31448414 |
| 30 | * synaptic transmission, glutamatergic (GO:0035249) | 4.26456886 |
| 31 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.23281588 |
| 32 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.17187438 |
| 33 | sodium ion export (GO:0071436) | 4.16712743 |
| 34 | central nervous system myelination (GO:0022010) | 4.12020076 |
| 35 | axon ensheathment in central nervous system (GO:0032291) | 4.12020076 |
| 36 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.11167505 |
| 37 | neuron cell-cell adhesion (GO:0007158) | 4.09483244 |
| 38 | * glutamate receptor signaling pathway (GO:0007215) | 4.09477112 |
| 39 | regulation of synapse maturation (GO:0090128) | 4.04897414 |
| 40 | proline transport (GO:0015824) | 3.98870695 |
| 41 | * neuron-neuron synaptic transmission (GO:0007270) | 3.97757640 |
| 42 | * long-term memory (GO:0007616) | 3.93155461 |
| 43 | neuromuscular process controlling balance (GO:0050885) | 3.92135312 |
| 44 | * regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.85237370 |
| 45 | positive regulation of synapse maturation (GO:0090129) | 3.80857262 |
| 46 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.79901750 |
| 47 | * positive regulation of membrane potential (GO:0045838) | 3.79295678 |
| 48 | neurotransmitter transport (GO:0006836) | 3.78241385 |
| 49 | neuromuscular process controlling posture (GO:0050884) | 3.73285785 |
| 50 | activation of protein kinase A activity (GO:0034199) | 3.72854082 |
| 51 | glycine transport (GO:0015816) | 3.72580786 |
| 52 | * regulation of synaptic plasticity (GO:0048167) | 3.72356933 |
| 53 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.70052462 |
| 54 | auditory behavior (GO:0031223) | 3.66716001 |
| 55 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.66548952 |
| 56 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.64586812 |
| 57 | * regulation of postsynaptic membrane potential (GO:0060078) | 3.64550497 |
| 58 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.64115308 |
| 59 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.61325327 |
| 60 | transmission of nerve impulse (GO:0019226) | 3.60103056 |
| 61 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.57994080 |
| 62 | regulation of neurotransmitter secretion (GO:0046928) | 3.56725836 |
| 63 | regulation of neurotransmitter levels (GO:0001505) | 3.54323683 |
| 64 | cell communication by electrical coupling (GO:0010644) | 3.51641846 |
| 65 | response to auditory stimulus (GO:0010996) | 3.48916987 |
| 66 | synaptic vesicle endocytosis (GO:0048488) | 3.48325178 |
| 67 | vesicle docking involved in exocytosis (GO:0006904) | 3.47409519 |
| 68 | acidic amino acid transport (GO:0015800) | 3.47112802 |
| 69 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.46140172 |
| 70 | neurotransmitter uptake (GO:0001504) | 3.40652110 |
| 71 | long-term synaptic potentiation (GO:0060291) | 3.39631848 |
| 72 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.38036835 |
| 73 | membrane depolarization during action potential (GO:0086010) | 3.37255762 |
| 74 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.37169351 |
| 75 | positive regulation of neurotransmitter transport (GO:0051590) | 3.36523356 |
| 76 | neuronal ion channel clustering (GO:0045161) | 3.36222147 |
| 77 | regulation of vesicle fusion (GO:0031338) | 3.33934394 |
| 78 | regulation of ARF protein signal transduction (GO:0032012) | 3.32385396 |
| 79 | regulation of neurotransmitter transport (GO:0051588) | 3.32202200 |
| 80 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.29537419 |
| 81 | membrane hyperpolarization (GO:0060081) | 3.28948238 |
| 82 | L-amino acid import (GO:0043092) | 3.26506070 |
| 83 | establishment of synaptic vesicle localization (GO:0097480) | 3.26429062 |
| 84 | synaptic vesicle transport (GO:0048489) | 3.26429062 |
| 85 | neuromuscular synaptic transmission (GO:0007274) | 3.26323335 |
| 86 | dendrite morphogenesis (GO:0048813) | 3.26218211 |
| 87 | neuron recognition (GO:0008038) | 3.25066076 |
| 88 | dendritic spine organization (GO:0097061) | 3.24997342 |
| 89 | cell differentiation in hindbrain (GO:0021533) | 3.24918346 |
| 90 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.24115347 |
| 91 | regulation of exocytosis (GO:0017157) | 3.21802281 |
| 92 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.21258470 |
| 93 | * membrane depolarization (GO:0051899) | 3.21063201 |
| 94 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.19847103 |
| 95 | neuromuscular process (GO:0050905) | 3.19270466 |
| 96 | vesicle docking (GO:0048278) | 3.18831479 |
| 97 | positive regulation of dendritic spine development (GO:0060999) | 3.18262805 |
| 98 | postsynaptic membrane organization (GO:0001941) | 3.13484349 |
| 99 | regulation of dendritic spine development (GO:0060998) | 3.13457190 |
| 100 | positive regulation of dendrite development (GO:1900006) | 3.12400315 |
| 101 | dicarboxylic acid transport (GO:0006835) | 3.11419030 |
| 102 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.10338264 |
| 103 | vesicle transport along microtubule (GO:0047496) | 3.10145933 |
| 104 | positive regulation of synaptic transmission (GO:0050806) | 3.09733391 |
| 105 | behavioral fear response (GO:0001662) | 3.09723768 |
| 106 | behavioral defense response (GO:0002209) | 3.09723768 |
| 107 | signal release (GO:0023061) | 3.09364332 |
| 108 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.08158577 |
| 109 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.08076439 |
| 110 | * learning (GO:0007612) | 3.07891972 |
| 111 | innervation (GO:0060384) | 3.07266692 |
| 112 | axonal fasciculation (GO:0007413) | 3.06474171 |
| 113 | * regulation of synaptic transmission (GO:0050804) | 3.05369797 |
| 114 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.04537629 |
| 115 | potassium ion import (GO:0010107) | 3.03025362 |
| 116 | * synaptic transmission (GO:0007268) | 3.00028720 |
| 117 | cellular sodium ion homeostasis (GO:0006883) | 2.97236949 |
| 118 | adult walking behavior (GO:0007628) | 2.96658063 |
| 119 | cerebellar Purkinje cell layer development (GO:0021680) | 2.95144149 |
| 120 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.95046100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.05519309 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.14967515 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11778851 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.09123905 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.08250823 |
| 6 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.01035034 |
| 7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.91038951 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.90401644 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.79767796 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.79767796 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.71340607 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.61071878 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.60347612 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58411297 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48776659 |
| 16 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.44538540 |
| 17 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41588603 |
| 18 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.39156599 |
| 19 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.38035491 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.35499404 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.33655412 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.33548658 |
| 23 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.31976547 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.23757643 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.20039999 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.15106916 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.06260246 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.91727309 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80788721 |
| 30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.75609461 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.67544787 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61245694 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.48057917 |
| 34 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.47110565 |
| 35 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.47008332 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.46956873 |
| 37 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37319780 |
| 38 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.35644987 |
| 39 | KDM2B_26808549_Chip-Seq_K562_Human | 1.35317630 |
| 40 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.34693906 |
| 41 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.30160405 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28457033 |
| 43 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26690428 |
| 44 | AR_19668381_ChIP-Seq_PC3_Human | 1.26011349 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25582302 |
| 46 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.25530788 |
| 47 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25378943 |
| 48 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.24627926 |
| 49 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.24591619 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.23758411 |
| 51 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20103135 |
| 52 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.19139950 |
| 53 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18857860 |
| 54 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.17829170 |
| 55 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17820986 |
| 56 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.16603106 |
| 57 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16180066 |
| 58 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15099223 |
| 59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14996581 |
| 60 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.14805105 |
| 61 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.13411365 |
| 62 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.12591094 |
| 63 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.12531993 |
| 64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.10997891 |
| 65 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.10773113 |
| 66 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.09311499 |
| 67 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09114441 |
| 68 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.08589710 |
| 69 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.08470441 |
| 70 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08168437 |
| 71 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08076553 |
| 72 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07758871 |
| 73 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.05445953 |
| 74 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03086427 |
| 75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02404426 |
| 76 | P300_19829295_ChIP-Seq_ESCs_Human | 1.01050351 |
| 77 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 1.00268381 |
| 78 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00017568 |
| 79 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99757160 |
| 80 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98968316 |
| 81 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.98594367 |
| 82 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97031500 |
| 83 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.96609079 |
| 84 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96127392 |
| 85 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.96057353 |
| 86 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95166047 |
| 87 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94829393 |
| 88 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93927565 |
| 89 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.93912278 |
| 90 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93912177 |
| 91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93805765 |
| 92 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.93796124 |
| 93 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93344455 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92923406 |
| 95 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92871270 |
| 96 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92860202 |
| 97 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92831295 |
| 98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92151625 |
| 99 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91787403 |
| 100 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.91675370 |
| 101 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.91385279 |
| 102 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91106746 |
| 103 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89260022 |
| 104 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.88843167 |
| 105 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87726207 |
| 106 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87578191 |
| 107 | P68_20966046_ChIP-Seq_HELA_Human | 0.87100694 |
| 108 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.87073234 |
| 109 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.86705165 |
| 110 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.86133119 |
| 111 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85728323 |
| 112 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.85363899 |
| 113 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.85218881 |
| 114 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85209410 |
| 115 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85107660 |
| 116 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.83284342 |
| 117 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82244372 |
| 118 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.81822670 |
| 119 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.81543134 |
| 120 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80695277 |
| 121 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.80627918 |
| 122 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.80577860 |
| 123 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.80339964 |
| 124 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.79189837 |
| 125 | * SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.78070326 |
| 126 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.77929051 |
| 127 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.75212624 |
| 128 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.73716768 |
| 129 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.72086582 |
| 130 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.71966850 |
| 131 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.71860174 |
| 132 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.70672835 |
| 133 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.70667823 |
| 134 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.70011023 |
| 135 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.69167664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0004859_abnormal_synaptic_plasticity | 7.09382330 |
| 2 | MP0003880_abnormal_central_pattern | 4.61937820 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.43660753 |
| 4 | MP0004270_analgesia | 3.85801587 |
| 5 | MP0002822_catalepsy | 3.57584625 |
| 6 | * MP0009745_abnormal_behavioral_response | 3.57011922 |
| 7 | * MP0002063_abnormal_learning/memory/cond | 3.48171335 |
| 8 | MP0009046_muscle_twitch | 3.34576521 |
| 9 | * MP0002064_seizures | 3.28686876 |
| 10 | MP0005423_abnormal_somatic_nervous | 3.06829413 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.95351806 |
| 12 | * MP0002572_abnormal_emotion/affect_behav | 2.82796168 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.69936093 |
| 14 | * MP0002272_abnormal_nervous_system | 2.66126551 |
| 15 | * MP0001486_abnormal_startle_reflex | 2.55725131 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.36306115 |
| 17 | MP0008569_lethality_at_weaning | 2.18808390 |
| 18 | MP0002736_abnormal_nociception_after | 2.15187694 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.11167278 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.04806678 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.02830633 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 2.01902071 |
| 23 | MP0001970_abnormal_pain_threshold | 2.00230491 |
| 24 | MP0002909_abnormal_adrenal_gland | 1.99000530 |
| 25 | MP0004858_abnormal_nervous_system | 1.90029746 |
| 26 | * MP0002067_abnormal_sensory_capabilities | 1.86840704 |
| 27 | MP0003329_amyloid_beta_deposits | 1.86317680 |
| 28 | * MP0004811_abnormal_neuron_physiology | 1.85384765 |
| 29 | MP0002184_abnormal_innervation | 1.75053948 |
| 30 | MP0003879_abnormal_hair_cell | 1.72918502 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.71528950 |
| 32 | MP0004924_abnormal_behavior | 1.71528950 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.71177876 |
| 34 | * MP0002557_abnormal_social/conspecific_i | 1.69657026 |
| 35 | MP0004885_abnormal_endolymph | 1.60219663 |
| 36 | MP0000778_abnormal_nervous_system | 1.58494888 |
| 37 | MP0000955_abnormal_spinal_cord | 1.58278736 |
| 38 | MP0003123_paternal_imprinting | 1.52108430 |
| 39 | MP0003787_abnormal_imprinting | 1.48936262 |
| 40 | MP0001984_abnormal_olfaction | 1.47254070 |
| 41 | * MP0002066_abnormal_motor_capabilities/c | 1.45735368 |
| 42 | * MP0002882_abnormal_neuron_morphology | 1.39595412 |
| 43 | * MP0003633_abnormal_nervous_system | 1.39364737 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.30643921 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.28290427 |
| 46 | MP0004142_abnormal_muscle_tone | 1.27130772 |
| 47 | MP0003283_abnormal_digestive_organ | 1.21233740 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.19254411 |
| 49 | MP0003075_altered_response_to | 1.18318556 |
| 50 | * MP0003631_nervous_system_phenotype | 1.17838341 |
| 51 | MP0006276_abnormal_autonomic_nervous | 1.17075071 |
| 52 | MP0001529_abnormal_vocalization | 1.10695288 |
| 53 | MP0001346_abnormal_lacrimal_gland | 1.09659211 |
| 54 | MP0008961_abnormal_basal_metabolism | 1.09489985 |
| 55 | * MP0002152_abnormal_brain_morphology | 1.07859622 |
| 56 | MP0004145_abnormal_muscle_electrophysio | 1.03625136 |
| 57 | MP0003690_abnormal_glial_cell | 1.03538816 |
| 58 | MP0001905_abnormal_dopamine_level | 1.03343960 |
| 59 | MP0001348_abnormal_lacrimal_gland | 1.01774694 |
| 60 | MP0003122_maternal_imprinting | 1.01181348 |
| 61 | MP0004147_increased_porphyrin_level | 0.99128141 |
| 62 | MP0002229_neurodegeneration | 0.97843838 |
| 63 | * MP0002069_abnormal_eating/drinking_beha | 0.95692270 |
| 64 | MP0000920_abnormal_myelination | 0.91213652 |
| 65 | MP0001188_hyperpigmentation | 0.90603637 |
| 66 | MP0003632_abnormal_nervous_system | 0.90145462 |
| 67 | MP0000751_myopathy | 0.89302848 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 0.88910355 |
| 69 | MP0000013_abnormal_adipose_tissue | 0.88413902 |
| 70 | * MP0008874_decreased_physiological_sensi | 0.87766899 |
| 71 | * MP0008872_abnormal_physiological_respon | 0.85589831 |
| 72 | MP0005535_abnormal_body_temperature | 0.83996608 |
| 73 | MP0003634_abnormal_glial_cell | 0.83219485 |
| 74 | MP0004085_abnormal_heartbeat | 0.83092487 |
| 75 | MP0000604_amyloidosis | 0.83027812 |
| 76 | MP0003172_abnormal_lysosome_physiology | 0.80838404 |
| 77 | MP0005551_abnormal_eye_electrophysiolog | 0.80000478 |
| 78 | MP0001986_abnormal_taste_sensitivity | 0.78240247 |
| 79 | MP0010386_abnormal_urinary_bladder | 0.76915260 |
| 80 | MP0004742_abnormal_vestibular_system | 0.76619031 |
| 81 | * MP0001177_atelectasis | 0.76580876 |
| 82 | MP0002090_abnormal_vision | 0.75058848 |
| 83 | MP0005499_abnormal_olfactory_system | 0.74370317 |
| 84 | MP0005394_taste/olfaction_phenotype | 0.74370317 |
| 85 | MP0004510_myositis | 0.73675739 |
| 86 | MP0001963_abnormal_hearing_physiology | 0.70914701 |
| 87 | MP0003137_abnormal_impulse_conducting | 0.67717130 |
| 88 | MP0005409_darkened_coat_color | 0.65291495 |
| 89 | MP0010234_abnormal_vibrissa_follicle | 0.64767411 |
| 90 | MP0004043_abnormal_pH_regulation | 0.63941253 |
| 91 | MP0001485_abnormal_pinna_reflex | 0.63536073 |
| 92 | MP0004130_abnormal_muscle_cell | 0.63490882 |
| 93 | MP0000631_abnormal_neuroendocrine_gland | 0.62833629 |
| 94 | MP0000579_abnormal_nail_morphology | 0.62416797 |
| 95 | MP0008877_abnormal_DNA_methylation | 0.61701321 |
| 96 | MP0004215_abnormal_myocardial_fiber | 0.61144540 |
| 97 | * MP0002752_abnormal_somatic_nervous | 0.61085589 |
| 98 | MP0005166_decreased_susceptibility_to | 0.60498014 |
| 99 | MP0004233_abnormal_muscle_weight | 0.58555023 |
| 100 | MP0001299_abnormal_eye_distance/ | 0.56335187 |
| 101 | MP0004484_altered_response_of | 0.55019039 |
| 102 | MP0005623_abnormal_meninges_morphology | 0.54733176 |
| 103 | MP0002638_abnormal_pupillary_reflex | 0.54463691 |
| 104 | * MP0010769_abnormal_survival | 0.54383858 |
| 105 | MP0001664_abnormal_digestion | 0.53718445 |
| 106 | MP0003045_fibrosis | 0.52482199 |
| 107 | * MP0003956_abnormal_body_size | 0.50900051 |
| 108 | * MP0010768_mortality/aging | 0.50863742 |
| 109 | * MP0002082_postnatal_lethality | 0.50405185 |
| 110 | * MP0010770_preweaning_lethality | 0.50405185 |
| 111 | * MP0001943_abnormal_respiration | 0.46263988 |
| 112 | MP0001765_abnormal_ion_homeostasis | 0.45138486 |
| 113 | * MP0002873_normal_phenotype | 0.44761905 |
| 114 | MP0003183_abnormal_peptide_metabolism | 0.44622559 |
| 115 | * MP0002169_no_abnormal_phenotype | 0.43081531 |
| 116 | MP0003861_abnormal_nervous_system | 0.42865486 |
| 117 | MP0000026_abnormal_inner_ear | 0.40838916 |
| 118 | MP0002089_abnormal_postnatal_growth/wei | 0.40633085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.91274626 |
| 2 | Focal motor seizures (HP:0011153) | 7.74495499 |
| 3 | Focal seizures (HP:0007359) | 5.99615842 |
| 4 | Visual hallucinations (HP:0002367) | 5.52276321 |
| 5 | Action tremor (HP:0002345) | 4.68549500 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.64923391 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.64890268 |
| 8 | Febrile seizures (HP:0002373) | 4.37423706 |
| 9 | Atonic seizures (HP:0010819) | 4.19555405 |
| 10 | Absence seizures (HP:0002121) | 3.98104481 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.89830450 |
| 12 | Ankle clonus (HP:0011448) | 3.84128748 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.82171765 |
| 14 | Poor eye contact (HP:0000817) | 3.71053798 |
| 15 | Cerebral hypomyelination (HP:0006808) | 3.70979662 |
| 16 | Gaze-evoked nystagmus (HP:0000640) | 3.66470520 |
| 17 | Dialeptic seizures (HP:0011146) | 3.64949390 |
| 18 | Broad-based gait (HP:0002136) | 3.59691785 |
| 19 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.57303367 |
| 20 | Depression (HP:0000716) | 3.56604129 |
| 21 | Dysdiadochokinesis (HP:0002075) | 3.45159184 |
| 22 | Postural instability (HP:0002172) | 3.39131224 |
| 23 | Abnormal social behavior (HP:0012433) | 3.36801412 |
| 24 | Impaired social interactions (HP:0000735) | 3.36801412 |
| 25 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.34699797 |
| 26 | Dysmetria (HP:0001310) | 3.34374868 |
| 27 | Papilledema (HP:0001085) | 3.32800509 |
| 28 | Mutism (HP:0002300) | 3.32623719 |
| 29 | Anxiety (HP:0000739) | 3.21401312 |
| 30 | Delusions (HP:0000746) | 3.21387551 |
| 31 | Abnormality of the lower motor neuron (HP:0002366) | 3.15051825 |
| 32 | Genetic anticipation (HP:0003743) | 3.12901946 |
| 33 | Impaired smooth pursuit (HP:0007772) | 3.08366897 |
| 34 | Torticollis (HP:0000473) | 3.08130804 |
| 35 | Abnormal eating behavior (HP:0100738) | 3.07184634 |
| 36 | Hemiplegia (HP:0002301) | 3.04024789 |
| 37 | Truncal ataxia (HP:0002078) | 3.03035836 |
| 38 | Intention tremor (HP:0002080) | 2.98548271 |
| 39 | Akinesia (HP:0002304) | 2.98115318 |
| 40 | Ventricular fibrillation (HP:0001663) | 2.96663804 |
| 41 | Annular pancreas (HP:0001734) | 2.86011051 |
| 42 | Focal dystonia (HP:0004373) | 2.85767258 |
| 43 | Scanning speech (HP:0002168) | 2.82667131 |
| 44 | Urinary urgency (HP:0000012) | 2.80052367 |
| 45 | Spastic gait (HP:0002064) | 2.74682955 |
| 46 | Hemiparesis (HP:0001269) | 2.72333406 |
| 47 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.70559548 |
| 48 | Dysmetric saccades (HP:0000641) | 2.68468837 |
| 49 | Stereotypic behavior (HP:0000733) | 2.67065245 |
| 50 | Bradykinesia (HP:0002067) | 2.64160088 |
| 51 | Amblyopia (HP:0000646) | 2.63890071 |
| 52 | Diplopia (HP:0000651) | 2.62248950 |
| 53 | Abnormality of binocular vision (HP:0011514) | 2.62248950 |
| 54 | Craniofacial dystonia (HP:0012179) | 2.52039875 |
| 55 | Pointed chin (HP:0000307) | 2.48159828 |
| 56 | Sleep apnea (HP:0010535) | 2.47972032 |
| 57 | Hyperventilation (HP:0002883) | 2.46010723 |
| 58 | Diminished motivation (HP:0000745) | 2.45281777 |
| 59 | Status epilepticus (HP:0002133) | 2.44961484 |
| 60 | Peripheral hypomyelination (HP:0007182) | 2.44359218 |
| 61 | Spastic tetraparesis (HP:0001285) | 2.43916579 |
| 62 | Impaired vibratory sensation (HP:0002495) | 2.43883348 |
| 63 | Megalencephaly (HP:0001355) | 2.42296044 |
| 64 | Drooling (HP:0002307) | 2.40458360 |
| 65 | Excessive salivation (HP:0003781) | 2.40458360 |
| 66 | Choreoathetosis (HP:0001266) | 2.38883224 |
| 67 | Progressive inability to walk (HP:0002505) | 2.37751238 |
| 68 | Neurofibrillary tangles (HP:0002185) | 2.35953518 |
| 69 | Bundle branch block (HP:0011710) | 2.35205248 |
| 70 | Epileptiform EEG discharges (HP:0011182) | 2.32484331 |
| 71 | Insomnia (HP:0100785) | 2.32039067 |
| 72 | CNS hypomyelination (HP:0003429) | 2.25903124 |
| 73 | EEG with generalized epileptiform discharges (HP:0011198) | 2.24792750 |
| 74 | Cerebral inclusion bodies (HP:0100314) | 2.20485363 |
| 75 | Lower limb muscle weakness (HP:0007340) | 2.20097352 |
| 76 | Clonus (HP:0002169) | 2.20096776 |
| 77 | Fetal akinesia sequence (HP:0001989) | 2.17950853 |
| 78 | Hypsarrhythmia (HP:0002521) | 2.16426851 |
| 79 | Obstructive sleep apnea (HP:0002870) | 2.12157270 |
| 80 | Abnormal EKG (HP:0003115) | 2.09931181 |
| 81 | Incomplete penetrance (HP:0003829) | 2.06955709 |
| 82 | Abnormality of saccadic eye movements (HP:0000570) | 2.06891108 |
| 83 | Tetraplegia (HP:0002445) | 2.06598450 |
| 84 | Abnormality of the corticospinal tract (HP:0002492) | 2.05961410 |
| 85 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.04225689 |
| 86 | Agitation (HP:0000713) | 2.03977619 |
| 87 | Absent speech (HP:0001344) | 2.03757072 |
| 88 | Neuronal loss in central nervous system (HP:0002529) | 2.01601139 |
| 89 | Resting tremor (HP:0002322) | 2.01244550 |
| 90 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.01011414 |
| 91 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.01011414 |
| 92 | Generalized myoclonic seizures (HP:0002123) | 2.00619958 |
| 93 | Gait ataxia (HP:0002066) | 2.00376702 |
| 94 | Lower limb amyotrophy (HP:0007210) | 1.97697518 |
| 95 | Insidious onset (HP:0003587) | 1.95672943 |
| 96 | Termporal pattern (HP:0011008) | 1.95672943 |
| 97 | Limb dystonia (HP:0002451) | 1.92992074 |
| 98 | Ankyloglossia (HP:0010296) | 1.92477933 |
| 99 | Memory impairment (HP:0002354) | 1.92466365 |
| 100 | Rigidity (HP:0002063) | 1.90195611 |
| 101 | Lower limb asymmetry (HP:0100559) | 1.89601121 |
| 102 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.87871733 |
| 103 | Aplasia of the phalanges of the hand (HP:0009802) | 1.87871733 |
| 104 | Aplasia involving bones of the extremities (HP:0009825) | 1.87871733 |
| 105 | Amyotrophic lateral sclerosis (HP:0007354) | 1.87239699 |
| 106 | Increased circulating renin level (HP:0000848) | 1.83896142 |
| 107 | Heart block (HP:0012722) | 1.83325519 |
| 108 | Polyphagia (HP:0002591) | 1.83043183 |
| 109 | Pheochromocytoma (HP:0002666) | 1.82724480 |
| 110 | Abnormality of the periventricular white matter (HP:0002518) | 1.80600450 |
| 111 | Inability to walk (HP:0002540) | 1.80159561 |
| 112 | Prolonged QT interval (HP:0001657) | 1.79507920 |
| 113 | Dementia (HP:0000726) | 1.78689050 |
| 114 | Upper limb amyotrophy (HP:0009129) | 1.78144391 |
| 115 | Distal upper limb amyotrophy (HP:0007149) | 1.78144391 |
| 116 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.77847590 |
| 117 | Spinal canal stenosis (HP:0003416) | 1.76141164 |
| 118 | Slow saccadic eye movements (HP:0000514) | 1.75899269 |
| 119 | Psychosis (HP:0000709) | 1.75897099 |
| 120 | Hand muscle atrophy (HP:0009130) | 1.75726734 |
| 121 | Unsteady gait (HP:0002317) | 1.75009477 |
| 122 | Inappropriate behavior (HP:0000719) | 1.74609088 |
| 123 | Apathy (HP:0000741) | 1.74557961 |
| 124 | Rapidly progressive (HP:0003678) | 1.71266139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.75075959 |
| 2 | NTRK3 | 4.72478112 |
| 3 | MAP3K9 | 4.11022495 |
| 4 | MARK1 | 2.81589689 |
| 5 | DAPK2 | 2.78965013 |
| 6 | MAP3K4 | 2.70249914 |
| 7 | MINK1 | 2.68889944 |
| 8 | PRKD3 | 2.58277751 |
| 9 | PAK6 | 2.55590366 |
| 10 | KSR2 | 2.31577494 |
| 11 | CAMKK1 | 2.27225210 |
| 12 | NTRK2 | 2.13573890 |
| 13 | MAP2K7 | 2.11712178 |
| 14 | NTRK1 | 1.92731839 |
| 15 | RIPK4 | 1.77914776 |
| 16 | STK38 | 1.73717127 |
| 17 | MAP2K4 | 1.68774864 |
| 18 | CDK5 | 1.63466855 |
| 19 | DAPK1 | 1.61587858 |
| 20 | KSR1 | 1.59723541 |
| 21 | TNIK | 1.58507666 |
| 22 | PRPF4B | 1.44953691 |
| 23 | MAP3K12 | 1.42244519 |
| 24 | TAOK1 | 1.33617011 |
| 25 | CAMKK2 | 1.33307950 |
| 26 | MAP3K2 | 1.30652964 |
| 27 | MAP3K13 | 1.30571737 |
| 28 | CDK19 | 1.28489434 |
| 29 | FES | 1.28065740 |
| 30 | ARAF | 1.26936111 |
| 31 | TYRO3 | 1.26380614 |
| 32 | SIK2 | 1.25628403 |
| 33 | PRKCG | 1.24097470 |
| 34 | GRK5 | 1.21756595 |
| 35 | UHMK1 | 1.19509439 |
| 36 | MAPK13 | 1.15994799 |
| 37 | CAMK1 | 1.11626603 |
| 38 | PLK2 | 1.10587398 |
| 39 | PRKCH | 1.06096654 |
| 40 | ALK | 1.04198304 |
| 41 | PINK1 | 1.00188257 |
| 42 | STK11 | 0.99527483 |
| 43 | SGK494 | 0.96156556 |
| 44 | SGK223 | 0.96156556 |
| 45 | CDK15 | 0.95565423 |
| 46 | CDK18 | 0.95314378 |
| 47 | PHKG2 | 0.91693209 |
| 48 | PHKG1 | 0.91693209 |
| 49 | RIPK1 | 0.91685083 |
| 50 | MAPK12 | 0.89938374 |
| 51 | LATS2 | 0.88063299 |
| 52 | CAMK2A | 0.87929964 |
| 53 | CDK14 | 0.87430992 |
| 54 | RAF1 | 0.85665341 |
| 55 | PNCK | 0.85644865 |
| 56 | CDK11A | 0.84088761 |
| 57 | SGK3 | 0.82866399 |
| 58 | SGK2 | 0.82407612 |
| 59 | RET | 0.80952821 |
| 60 | LMTK2 | 0.79612034 |
| 61 | CASK | 0.78039493 |
| 62 | MARK2 | 0.76470630 |
| 63 | PDK1 | 0.75819365 |
| 64 | MAP3K11 | 0.75347871 |
| 65 | CAMK2B | 0.73751232 |
| 66 | PAK3 | 0.73640442 |
| 67 | SGK1 | 0.72564883 |
| 68 | PDPK1 | 0.68332662 |
| 69 | BRAF | 0.67195726 |
| 70 | MAP3K1 | 0.66756202 |
| 71 | TNK2 | 0.66447560 |
| 72 | NEK1 | 0.66245780 |
| 73 | CDC42BPA | 0.64638646 |
| 74 | DYRK1A | 0.63415566 |
| 75 | PKN1 | 0.62681669 |
| 76 | PTK2B | 0.62578722 |
| 77 | BRSK1 | 0.60799348 |
| 78 | BMPR2 | 0.60227499 |
| 79 | LIMK1 | 0.59460036 |
| 80 | SCYL2 | 0.57782345 |
| 81 | CAMK4 | 0.56139764 |
| 82 | WNK1 | 0.56093906 |
| 83 | OXSR1 | 0.53885821 |
| 84 | * RPS6KA3 | 0.53292769 |
| 85 | CSNK1G2 | 0.52649735 |
| 86 | MAP3K7 | 0.52454117 |
| 87 | CAMK1G | 0.51357488 |
| 88 | PRKCZ | 0.50077872 |
| 89 | MAPK10 | 0.48461993 |
| 90 | FYN | 0.48169725 |
| 91 | TESK1 | 0.46204797 |
| 92 | CAMK2G | 0.45870749 |
| 93 | PRKG2 | 0.44526960 |
| 94 | ROCK2 | 0.44505161 |
| 95 | DAPK3 | 0.42424099 |
| 96 | FGFR2 | 0.40282404 |
| 97 | CAMK2D | 0.39917579 |
| 98 | CCNB1 | 0.37038687 |
| 99 | PRKCE | 0.36316378 |
| 100 | MAP2K1 | 0.36228875 |
| 101 | DMPK | 0.34751176 |
| 102 | IRAK2 | 0.33061174 |
| 103 | * PRKCB | 0.30235630 |
| 104 | ROCK1 | 0.29882518 |
| 105 | RPS6KA2 | 0.29511731 |
| 106 | ERBB2 | 0.29416469 |
| 107 | PRKD2 | 0.28944173 |
| 108 | MAPK8 | 0.28170919 |
| 109 | MAP2K6 | 0.27789332 |
| 110 | * PRKCA | 0.27104931 |
| 111 | FER | 0.27098932 |
| 112 | CSNK1A1 | 0.24793390 |
| 113 | BMX | 0.23662320 |
| 114 | JAK2 | 0.23521544 |
| 115 | CAMK1D | 0.20820232 |
| 116 | GSK3B | 0.20275390 |
| 117 | MAPKAPK5 | 0.19793634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Nicotine addiction_Homo sapiens_hsa05033 | 3.44494936 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.32092298 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.92141976 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.76926639 |
| 5 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.72668034 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.62433152 |
| 7 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.61213903 |
| 8 | * Long-term potentiation_Homo sapiens_hsa04720 | 2.59359373 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.56666907 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.36386166 |
| 11 | * Amphetamine addiction_Homo sapiens_hsa05031 | 2.35283138 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.27146307 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.15845030 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.14496288 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.01502195 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.99946400 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.98700496 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.80104638 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.76382342 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.69949505 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.67830572 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.67798733 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.60638740 |
| 24 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.56978997 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.53426357 |
| 26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.51603449 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.51537108 |
| 28 | * Cocaine addiction_Homo sapiens_hsa05030 | 1.49770293 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49599376 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.41504923 |
| 31 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.37716501 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.35139975 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.34587086 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.33061363 |
| 35 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.29918847 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.23484094 |
| 37 | Glioma_Homo sapiens_hsa05214 | 1.19295163 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.17224620 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04938375 |
| 40 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04343844 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03351558 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.03244232 |
| 43 | Melanogenesis_Homo sapiens_hsa04916 | 1.02068321 |
| 44 | Axon guidance_Homo sapiens_hsa04360 | 0.99532561 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96776307 |
| 46 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.95624522 |
| 47 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94249320 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93229024 |
| 49 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.90547439 |
| 50 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.86131766 |
| 51 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.85493845 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.83964047 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83707962 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77695436 |
| 55 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.75990274 |
| 56 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74517277 |
| 57 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73271562 |
| 58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73001556 |
| 59 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71785374 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69863774 |
| 61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67708506 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65903682 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 0.64017371 |
| 64 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63553003 |
| 65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62040728 |
| 66 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61342090 |
| 67 | Phototransduction_Homo sapiens_hsa04744 | 0.60111277 |
| 68 | Endocytosis_Homo sapiens_hsa04144 | 0.56673132 |
| 69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56155368 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55412028 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54254663 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54101996 |
| 73 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53901869 |
| 74 | * Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51783586 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51551827 |
| 76 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.50213297 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50104154 |
| 78 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49660306 |
| 79 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48923666 |
| 80 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47073670 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46496389 |
| 82 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.45185710 |
| 83 | * Alcoholism_Homo sapiens_hsa05034 | 0.44721170 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44669915 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44480673 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43664112 |
| 87 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43474224 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.42361583 |
| 89 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41414402 |
| 90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.41217118 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40436664 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39525717 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36878471 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36581111 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36000494 |
| 96 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35996810 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | 0.35630033 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32565674 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32476997 |
| 100 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.30800477 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30414294 |
| 102 | Histidine metabolism_Homo sapiens_hsa00340 | 0.30238550 |
| 103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29804653 |
| 104 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29298578 |
| 105 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29166548 |
| 106 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28152663 |
| 107 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.27623715 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24015856 |
| 109 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.21875621 |
| 110 | Tight junction_Homo sapiens_hsa04530 | 0.21741400 |
| 111 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.19581052 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.18297949 |
| 113 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.17297960 |

